Biodelivery Sciences International reported $41.09M in Sales Revenues for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acelrx Pharmaceuticals ACRX:US $ 1.86M 1.42M
Adamas Pharmaceuticals ADMS:US 25.9M 3.92M
Agile Therapeutics AGRX:US 1.29M 102K
Alimera Sciences ALIM:US $ 12.15M 9.55M
Biocryst Pharmaceuticals BCRX:US $ 40.99M 8.96M
Biodelivery Sciences International BDSI:US $ 41.09M 0.35M
Cara Therapeutics CARA:US $ 20.27M 20.27M
Daiichi Sankyo 4568:JP Y 265896M 1827M
Depomed DEPO:US $ 25.47M 0.1M
Endo International Ordinary Shares ENDP:US $ 772.03M 58.2M
JAZZ PHA JAZZ:US $ 838.12M 86.3M
Johnson & Johnson JNJ:US $ 23338M 26M
Knight Therapeutics Inc GUD:CN C$ 73.34M 7.54M
Lannett LCI:US $ 101.52M 4.48M
Mannkind MNKD:US $ 22.21M 1.07M
Nektar Therapeutics NKTR:US $ 24.92M 3.41M
Pacira Pharmaceuticals PCRX:US $ 127.72M 7.87M
Pfizer PFE:US $ 24094M 5117M
Redhill Biopharma RDHL:US $ 21.61M 0.11M
Revance Therapeutics RVNC:US $ 19.74M 0.94M
Teva Pharmaceutical TEVA:IT 3.89B 23M